- Home
- COCP vs CARM Comparison
COCP vs CARM Comparison
Compare COCP & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- CARM
- Stock Information
- Founded
- COCP 2006
- CARM 2016
- Country
- COCP United States
- CARM United States
- Employees
- COCP N/A
- CARM N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- COCP Health Care
- CARM Health Care
- Exchange
- COCP Nasdaq
- CARM Nasdaq
- Market Cap
- COCP 15.4M
- CARM 16.4M
- IPO Year
- COCP N/A
- CARM N/A
- Fundamental
- Price
- COCP $1.60
- CARM $0.28
- Analyst Decision
- COCP Strong Buy
- CARM Hold
- Analyst Count
- COCP 1
- CARM 5
- Target Price
- COCP $6.00
- CARM $0.90
- AVG Volume (30 Days)
- COCP 169.4K
- CARM 431.1K
- Earning Date
- COCP 08-22-2025
- CARM 08-19-2025
- Dividend Yield
- COCP N/A
- CARM N/A
- EPS Growth
- COCP N/A
- CARM N/A
- EPS
- COCP N/A
- CARM N/A
- Revenue
- COCP N/A
- CARM $10,767,000.00
- Revenue This Year
- COCP N/A
- CARM N/A
- Revenue Next Year
- COCP N/A
- CARM N/A
- P/E Ratio
- COCP N/A
- CARM N/A
- Revenue Growth
- COCP N/A
- CARM N/A
- 52 Week Low
- COCP $1.12
- CARM $0.14
- 52 Week High
- COCP $3.26
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- COCP 46.18
- CARM 34.10
- Support Level
- COCP $1.56
- CARM $0.26
- Resistance Level
- COCP $2.19
- CARM $0.41
- Average True Range (ATR)
- COCP 0.14
- CARM 0.03
- MACD
- COCP -0.02
- CARM -0.01
- Stochastic Oscillator
- COCP 6.35
- CARM 10.47
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.